▼ SELL
10b5-1 Plan
$ Value
$188K
Shares
17,801
Price
$11
Filed
Nov 12
Insider
Name
DeGolyer Donald W
Title
—
CIK
0001583098
Roles
Director
Transaction Details
Transaction Date
2025-11-10
Code
S
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
119,858
Footnotes
Represents the number of shares sold by the Reporting Person. Shares were sold pursuant to a Rule 10b5-1 trading plan, dated August 11, 2025, for the purpose of satisfying tax obligations relating to the vesting of RSUs on October 2, 2025. | For reporting purposes, sales prices within a $1 range have been aggregated and the weighted average sales price has been reported. The price ranges were: $10.33 - $10.79. The Company maintains a record of the transactions and copies will be provided upon request.
Filing Info
DeGolyer Donald W's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2025-11-10 | EBS | ▼ | $188K |
| 2025-08-12 | EBS | ▼ | $68K |
| 2025-04-30 | EBS | A | $0 |
| 2025-04-30 | EBS | A | $0 |
Other Insiders at EBS (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| FOWLER JOHN D JR | — | — | 2026-03-03 |
|
LINDAHL RICHARD S
EVP, Chief Financial Officer
|
— | — | 2026-03-05 |
|
PAPA JOSEPH C
President and CEO
|
— | — | 2026-03-05 |
|
Glessner Coleen
EVP, Quality & Ethics, and CPL
|
— | — | 2026-03-05 |
|
Williams Paul Anthony
SVP, Products Business
|
— | $34K | 2026-04-01 |
|
Hartzel William
SVP, Bioservices
|
— | — | 2026-03-05 |
|
Perl Jessica
SVP, General Counsel, Corp Sec
|
— | — | 2026-03-05 |
|
Lowry Simon C
SVP, R&D, CMO
|
— | — | 2026-03-05 |